00000000|MMI|127.77|Portugal|C0032729|[geoa]|["PO"-tx-3-"PO"-noun-0,"PO"-tx-2-"PO"-noun-0]|TX|[1102/2],[1138/2],[1205/2],[1284/2];[499/2],[535/2],[570/2],[616/2],[669/2],[932/2]|Z01.542.727
00000000|MMI|125.20|Patient Discharge|C0030685|[hlca]|["Discharge"-tx-28-"DISCHARGE"-noun-0,"Discharge"-tx-24-"discharge"-noun-0,"Discharge"-tx-4-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0,"Patient Discharge"-tx-1-"DISCHARGE PATIENT"-noun-0]|TX|[3517/9],[3657/9];3295/9;1503/9;158/9;255/17|E02.204.125;E02.760.400.610;N02.421.192.125;N02.421.585.400.610;N04.590.233.727.210.125
00000000|MMI|100.61|Mongolia|C0026410|[geoa]|["MG"-tx-3-"MG"-noun-0,"MG"-tx-2-"MG"-noun-0]|TX|[1099/2],[1202/2],[1281/2];[532/2],[613/2],[650/2],[929/2]|Z01.252.474.651
00000000|MMI|66.63|Coronary Artery Bypass Surgery|C0010055|[topp]|["CABG"-tx-10-"CABG"-noun-0,"CABG"-tx-5-"CABG"-noun-0,"CABG"-tx-4-"cabg"-noun-0,"Cardiac bypass surgery"-tx-4-"cardiac bypass surgery"-noun-0]|TX|2345/4;2088/4;1824/4;1835/14,1856/7|E04.100.376.719.332;E04.100.814.868.750;E04.928.220.520.220
00000000|MMI|61.19|Obesity|C0028754|[dsyn]|["OBESITY"-tx-4-"obesity"-noun-0]|TX|[1684/7],[1694/7]|C18.654.726.500;C23.888.144.699.500;E01.370.600.115.100.160.120.699.500;G07.100.100.160.120.699.500
00000000|MMI|59.06|Lasix|C0699992|[orch,phsu]|["Lasix"-tx-17-"Lasix"-noun-0,"Lasix"-tx-10-"lasix"-noun-0,"Lasix"-tx-2-"LASIX"-noun-0]|TX|2968/5;2534/5;508/5|D02.065.884.725.300;D02.092.146.807.300;D02.886.590.700.725.300
00000000|MMI|58.92|Isordil|C0590720|[orch,phsu]|["Isordil"-tx-17-"isordil"-noun-0,"Isordil"-tx-10-"isordil"-noun-0,"Isordil"-tx-2-"ISORDIL"-noun-0]|TX|2953/7;2518/7;577/7|D02.033.800.813.480.500;D09.853.813.480.500
00000000|MMI|58.37|Aspirin|C0004057|[orch,phsu]|["ASA"-tx-16-"ASA"-noun-0,"ASA"-tx-10-"ASA"-noun-0]|TX|2875/3;2502/3|D02.455.426.559.389.657.410.595.176
00000000|MMI|49.80|Metformin|C0025598|[orch,phsu]|["METFORMIN"-tx-20-"metformin"-noun-0,"METFORMIN"-tx-10-"metformin"-noun-0,"METFORMIN"-tx-3-"METFORMIN"-noun-0]|TX|3093/9;2463/9;1186/9|D02.078.370.141.450
00000000|MMI|49.30|Glyburide|C0017628|[orch,phsu]|["GLYBURIDE"-tx-20-"glyburide"-noun-0,"GLYBURIDE"-tx-10-"glyburide"-noun-0,"GLYBURIDE"-tx-2-"GLYBURIDE"-noun-0]|TX|3113/9;2444/9;554/9|D02.886.590.795.575;D02.948.828.575
00000000|MMI|48.50|diagnosis aspect|C1704338|[qlco]|["diagnosis"-tx-4-"DIAGNOSIS"-noun-0]|TX|[1478/9],[1582/9]|x.x.x.x.x.x.x
00000000|MMI|46.48|Daily|C0332173|[tmco]|["Daily"-tx-17-"daily"-adv-0,"Daily"-tx-16-"daily"-adv-0,"Daily"-tx-10-"Daily"-adv-0,"Daily"-tx-10-"daily"-adv-0,"Daily"-tx-3-"DAILY"-adj-0,"Daily"-tx-2-"DAILY"-adj-0]|TX|2945/5;2914/5;[2494/5],[2560/5],[2612/5];[2510/5],[2634/5];1141/5;[502/5],[935/5]|
00000000|MMI|45.68|Cerebroside-Sulfatase|C0007804|[aapp,enzy]|["ASA"-tx-16-"ASA"-noun-0,"ASA"-tx-10-"ASA"-noun-0]|TX|2875/3;2502/3|D08.811.277.352.827.070.250
00000000|MMI|45.36|Digoxin|C0012265|[orch,phsu]|["DIGOXIN"-tx-18-"digoxin"-noun-0,"DIGOXIN"-tx-10-"digoxin"-noun-0]|TX|3049/7;2599/7|D04.808.155.580.130.500.436;D04.808.155.580.130.688;D09.408.180.261.436
00000000|MMI|45.33|Dilantin|C0699512|[orch,phsu]|["Dilantin"-tx-24-"dilantin"-noun-0,"Dilantin"-tx-2-"DILANTIN"-noun-0]|TX|3244/8;623/8|D03.383.129.308.432.555.730
00000000|MMI|45.33|Oral|C0442027|[spco]|["PO"-tx-3-"PO"-noun-0,"PO"-tx-2-"PO"-noun-0]|TX|[1102/2],[1138/2],[1205/2],[1284/2];[499/2],[535/2],[570/2],[616/2],[669/2],[932/2]|
00000000|MMI|45.09|Coding|C0009219|[ocac]|["code"-tx-2-"CODE"-noun-0,"code"-tx-2-"code"-noun-0]|TX|419/4;437/4|N04.452.758.708.200.400.500;N04.452.859.564.274;N05.715.360.300.715.500.249;N06.850.520.308.940.968.249
00000000|MMI|40.09|Dyslipidemias|C0242339|[dsyn]|["Dyslipidemia"-tx-10-"dyslipidemia"-noun-0,"Dyslipidemia"-tx-4-"dyslipidemia"-noun-0]|TX|2391/12;[1704/12],[1719/12]|C18.452.584.500
00000000|MMI|39.61|benazepril|C0053091|[orch,phsu]|["BENAZEPRIL"-tx-18-"benazepril"-noun-0,"BENAZEPRIL"-tx-10-"benazepril"-noun-0,"BENAZEPRIL"-tx-3-"BENAZEPRIL"-noun-0]|TX|3019/10;2620/10;1147/10|x.x.x.x
00000000|MMI|39.03|Toprol|C2723006|[phsu]|["Toprol"-tx-17-"Toprol"-noun-0,"Toprol"-tx-10-"toprol"-noun-0]|TX|2934/6;2483/6|D02.033.100.624.698.573;D02.033.755.624.698.573;D02.092.063.624.698.573
00000000|MMI|35.81|Togo|C0040363|[geoa]|["TO"-tx-20-"to"-adv-0,"TO"-tx-16-"to"-adv-0]|TX|3085/2;2869/2|Z01.058.290.190.800
00000000|MMI|35.81|Tryptophanase|C0041260|[aapp,enzy]|["TO"-tx-20-"to"-adv-0,"TO"-tx-16-"to"-adv-0]|TX|3085/2;2869/2|D08.811.520.224.800
00000000|MMI|33.08|Seizures|C0036572|[sosy]|["seizure d"-tx-10-"Seizure d"-noun-0,"SEIZURE"-tx-4-"seizure"-noun-0]|TX|2314/9;1866/7|C10.228.140.490.631;C10.597.742;C23.888.592.742
00000000|MMI|32.68|Three times daily|C0556984|[tmco]|["TID"-tx-24-"TID"-noun-0,"TID"-tx-17-"tid"-noun-0,"TID"-tx-10-"TID"-noun-0,"TID"-tx-10-"tid"-noun-0,"TID"-tx-3-"TID"-noun-0,"TID"-tx-2-"TID"-noun-0]|TX|3238/3;2964/3;2593/3;2477/3;[1105/3],[1208/3],[1287/3];619/3|
00000000|MMI|32.68|three times a day at institution-specified times|C1610169|[tmco]|["TID"-tx-24-"TID"-noun-0,"TID"-tx-17-"tid"-noun-0,"TID"-tx-10-"TID"-noun-0,"TID"-tx-10-"tid"-noun-0,"TID"-tx-3-"TID"-noun-0,"TID"-tx-2-"TID"-noun-0]|TX|3238/3;2964/3;2593/3;2477/3;[1105/3],[1208/3],[1287/3];619/3|
00000000|MMI|32.42|Food-Drug Interactions|C0242785|[dsyn]|["Interaction, Food-Drug"-tx-2-"Food/Drug Interaction"-noun-0]|TX|[772/21],[941/21]|G07.690.773.968.511
00000000|MMI|32.28|Patent ductus arteriosus|C0013274|[cgab]|["PDA"-tx-13-"PDA"-noun-0,"PDA"-tx-5-"PDA"-noun-0]|TX|2740/3;2132/3|C14.240.400.340;C14.280.400.340;C16.131.240.400.340
00000000|MMI|30.65|Hypertensive disease|C0020538|[dsyn]|["HTN"-tx-10-"HTN"-noun-0,"HTN"-tx-4-"htn"-noun-0,"HYPERTENSION"-tx-4-"hypertension"-noun-0]|TX|2352/3;1734/3;1740/12|C14.907.489
00000000|MMI|30.56|Disease|C0012634|[dsyn]|["condition"-tx-28-"CONDITION"-noun-0,"Disorder"-tx-10-"disorder"-noun-0,"condition"-tx-4-"Conditions"-noun-0]|TX|3527/9;2380/8;1592/10|C23.550.288
00000000|MMI|27.49|Transplanted tissue|C0332835|[tisu]|["GRAFT"-tx-13-"graft"-noun-0,"GRAFT"-tx-5-"graft"-noun-0,"GRAFT"-tx-4-"graft"-noun-0]|TX|[2731/5],[2762/5];2123/5;1850/5|A01.941
00000000|MMI|26.96|Magnesium Cation|C2346927|[elii,phsu]|["Mg++"-tx-3-"MG"-noun-0,"Mg++"-tx-2-"MG"-noun-0]|TX|[1099/2],[1202/2],[1281/2];[532/2],[613/2],[650/2],[929/2]|
00000000|MMI|26.96|Milligram percent|C1960952|[qnco]|["mg %"-tx-3-"MG"-noun-0,"mg %"-tx-2-"MG"-noun-0]|TX|[1099/2],[1202/2],[1281/2];[532/2],[613/2],[650/2],[929/2]|
00000000|MMI|26.96|mg/dL|C0439269|[qnco]|["mg%"-tx-3-"MG"-noun-0,"mg%"-tx-2-"MG"-noun-0]|TX|[1099/2],[1202/2],[1281/2];[532/2],[613/2],[650/2],[929/2]|
00000000|MMI|24.11|Phenytoin|C0031507|[orch,phsu]|["PHENYTOIN"-tx-2-"PHENYTOIN"-noun-0]|TX|634/9|D03.383.129.308.432.555.730
00000000|MMI|24.11|Surgical aspects|C0038895|[ftcn]|["operations"-tx-4-"OPERATIONS"-noun-0]|TX|1895/10|x.x.x.x.x.x.x
00000000|MMI|23.30|100%|C3817553|[qnco]|["100%"-tx-17-"100"-integer-0,"100%"-tx-15-"100"-percentage-0,"100%"-tx-10-"100"-integer-0,"100%"-tx-2-"100"-integer-0]|TX|2941/3;[2818/3],[2833/3],[2844/3];2490/3;925/3|
00000000|MMI|22.85|10%|C3842590|[fndg]|["10%"-tx-28-"10"-integer-0,"10%"-tx-18-"10"-integer-0,"10%"-tx-10-"10"-integer-0,"10%"-tx-3-"10"-integer-0,"10%"-tx-2-"10"-integer-0]|TX|3634/2;3044/2;[2454/2],[2631/2];1158/2;564/2|
00000000|MMI|22.40|therapeutic aspects|C0039798|[ftcn]|["treatment"-tx-4-"Treatment"-noun-0]|TX|1644/9|x.x.x.x.x.x.x
00000000|MMI|20.95|Furosemide|C0016860|[orch,phsu]|["FUROSEMIDE"-tx-2-"FUROSEMIDE"-noun-0]|TX|516/10|D02.065.884.725.300;D02.092.146.807.300;D02.886.590.700.725.300
00000000|MMI|20.95|Isosorbide Dinitrate|C0022252|[orch,phsu]|["ISOSORBIDE DINITRATE"-tx-2-"ISOSORBIDE DINITRATE"-noun-0]|TX|587/20|D02.033.800.813.480.500;D09.853.813.480.500
00000000|MMI|20.95|Toprol-XL|C0723783|[orch,phsu]|["Toprol XL"-tx-2-"TOPROL XL"-noun-0]|TX|873/9|D02.033.100.624.698.573;D02.033.755.624.698.573;D02.092.063.624.698.573
00000000|MMI|19.59|Appointments|C0003629|[idcn]|["Appointment"-tx-4-"appointment"-noun-0,"Appointment"-tx-3-"APPOINTMENT"-noun-0]|TX|1445/11;1409/11|N04.452.095
00000000|MMI|19.36|Meal (occasion for eating)|C1998602|[dora]|["Meals"-tx-2-"meals"-noun-0]|TX|998/5|F01.145.407.432.500;F01.145.466.349.500;G07.203.300.590;G07.203.650.353.432.500;J02.500.590
00000000|MMI|19.31|CALD1 wt Allele|C3813548|[gngm]|["CAD"-tx-10-"CAD"-noun-0,"CAD"-tx-4-"cad"-noun-0,"CAD"-tx-1-"cad"-adj-0]|TX|2339/3;[1489/3],[1572/3],[1755/3];65/3|
00000000|MMI|19.31|District of Columbia|C0012764|[geoa]|["D.C."-tx-1-"D/C"-noun-0]|TX|333/3|Z01.107.567.875.500.210;Z01.433.429
00000000|MMI|18.90|Body Fluid Discharge|C0012621|[bdsu]|["Discharge"-tx-28-"DISCHARGE"-noun-0,"Discharge"-tx-24-"discharge"-noun-0,"Discharge"-tx-4-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|[3517/9],[3657/9];3295/9;1503/9;158/9|
00000000|MMI|18.90|Discharge, body substance|C2926602|[bdsu]|["Discharge"-tx-28-"DISCHARGE"-noun-0,"Discharge"-tx-24-"discharge"-noun-0,"Discharge"-tx-4-"DISCHARGE"-noun-0,"Discharge"-tx-1-"DISCHARGE"-noun-0]|TX|[3517/9],[3657/9];3295/9;1503/9;158/9|
00000000|MMI|18.47|20%|C3842589|[fndg]|["20%"-tx-26-"20"-fraction-0,"20%"-tx-17-"20"-integer-0,"20%"-tx-10-"20"-integer-0,"20%"-tx-2-"20"-integer-0]|TX|3380/2;2961/2;2540/2;[529/2],[610/2]|
00000000|MMI|18.34|Home environment|C0442519|[cnce]|["HOME"-tx-24-"home"-noun-0,"HOME"-tx-22-"home"-noun-0,"house"-tx-18-"house"-adj-0,"house"-tx-3-"House"-noun-0,"HOME"-tx-2-"Home"-noun-0]|TX|3318/4;3202/4;3011/5;1297/5;455/4|
00000000|MMI|17.80|Coronary Arteriosclerosis|C0010054|[dsyn]|["coronary artery disease"-tx-4-"coronary artery disease"-noun-0]|TX|1761/23|C14.280.647.250.260;C14.907.137.126.339;C14.907.585.250.260
00000000|MMI|17.80|Coronary Artery Disease|C1956346|[dsyn]|["CORONARY ARTERY DISEASE"-tx-4-"coronary artery disease"-noun-0]|TX|1761/23|C14.280.647.250.260;C14.907.137.126.339;C14.907.585.250.260
00000000|MMI|17.80|Dominican Republic|C0013014|[geoa]|["DR"-tx-3-"Dr"-noun-0]|TX|1427/2|Z01.107.084.900.300;Z01.639.880.300
00000000|MMI|16.77|Hypersensitivity|C0020517|[patf]|["Allergies"-tx-11-"Allergies"-noun-0,"ALLERGY"-tx-4-"ALLERGY"-noun-0]|TX|2642/9;1459/7|C20.543
00000000|MMI|16.37|Exercise stress test|C0015260|[diap]|["stress test"-tx-4-"stress test"-noun-0]|TX|2054/11|E01.370.370.380.250;E01.370.386.700.250;E05.333.250
00000000|MMI|16.37|Stress Test|C3494508|[diap]|["Stress Test"-tx-4-"stress test"-noun-0]|TX|2054/11|E01.370.370.380.250;E01.370.386.700.250;E05.333.250
00000000|MMI|16.34|Fat-Restricted Diet|C0242970|[topp]|["Low fat diet, NOS"-tx-3-"Low fat DIET"-noun-0]|TX|1305/3,1324/8|E02.642.249.260;G07.203.650.240.260
00000000|MMI|16.30|Cicatrix|C2004491|[patf]|["Scar NOS"-tx-8-"scar"-noun-0]|TX|2237/4|A10.165.450.300;C23.550.355.274;G16.100.856.891.249
00000000|MMI|16.30|Lisinopril|C0065374|[aapp,phsu]|["Lysinopril"-tx-18-"lisinopril"-noun-0]|TX|3033/10|D12.644.456.345.600
00000000|MMI|16.25|Lipitor|C0593906|[orch,phsu]|["Lipitor"-tx-10-"lipitor"-noun-0]|TX|2549/7|D03.383.129.578.075;D10.251.450.200
00000000|MMI|16.21|Glucophage|C0591573|[orch,phsu]|["Glucophage"-tx-3-"GLUCOPHAGE"-noun-0]|TX|1173/10|D02.078.370.141.450
00000000|MMI|16.17|Latvia|C0023128|[geoa]|["LV"-tx-13-"LV"-noun-0]|TX|2748/2|Z01.542.248.136.560;Z01.586.950.140.560
00000000|MMI|16.05|Oman|C0028971|[geoa]|["OM"-tx-14-"OM"-noun-0]|TX|2791/2|Z01.252.245.500.600
00000000|MMI|15.79|Congestive heart failure|C0018802|[dsyn]|["CHF"-tx-10-"CHF"-noun-0,"CHF"-tx-4-"chf"-noun-0,"CONGESTIVE HEART FAILURE"-tx-4-"congestive heart failure"-noun-0]|TX|2333/3;1787/3;1793/24|
00000000|MMI|15.79|Take|C1515187|[hlca]|["Take"-tx-26-"take"-verb-0,"Take"-tx-2-"Take"-verb-0,"Take"-tx-2-"take"-verb-0]|TX|3442/4;975/4;745/4|
00000000|MMI|15.10|Instruction [Publication Type]|C0302828|[inpr]|["instructions"-tx-3-"Instructions"-noun-0,"Instruction"-tx-2-"Instruction"-noun-0,"instructions"-tx-2-"Instructions"-noun-0]|TX|1212/12;[794/11],[963/11];726/12|
00000000|MMI|15.10|Instructions|C1442085|[idcn]|["Instructions"-tx-3-"Instructions"-noun-0,"Instructions"-tx-2-"Instructions"-noun-0,"instruction"-tx-2-"Instruction"-noun-0]|TX|1212/12;726/12;[794/11],[963/11]|
00000000|MMI|15.00|MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME|C3280240|[dsyn]|["MEDS"-tx-24-"meds"-noun-0,"MEDS"-tx-24-"meds"-noun-1,"MEDS"-tx-17-"meds"-noun-0,"MEDS"-tx-10-"Meds"-noun-0]|TX|[3287/4],[3323/4];[3287/4],[3323/4];2928/4;2404/4|
00000000|MMI|14.92|+2|C0740116|[qnco]|["+2"-tx-28-"2"-fraction-0,"+2"-tx-19-"2"-integer-0,"+2"-tx-3-"2"-integer-0,"+2"-tx-1-"2"-fraction-0]|TX|3624/1;3064/1;1068/1;277/1|
00000000|MMI|14.92|2+|C3833492|[fndg]|["2+"-tx-28-"2"-fraction-0,"2+"-tx-19-"2"-integer-0,"2+"-tx-3-"2"-integer-0,"2+"-tx-1-"2"-fraction-0]|TX|3624/1;3064/1;1068/1;277/1|
00000000|MMI|14.92|2+ Score|C2827735|[qnco]|["2+"-tx-28-"2"-fraction-0,"2+"-tx-19-"2"-integer-0,"2+"-tx-3-"2"-integer-0,"2+"-tx-1-"2"-fraction-0]|TX|3624/1;3064/1;1068/1;277/1|
00000000|MMI|14.92|2+ Score, WHO|C2981700|[clas]|["2+"-tx-28-"2"-fraction-0,"2+"-tx-19-"2"-integer-0,"2+"-tx-3-"2"-integer-0,"2+"-tx-1-"2"-fraction-0]|TX|3624/1;3064/1;1068/1;277/1|
00000000|MMI|14.64|Coronary heart disease|C0010068|[dsyn]|["Coronary (artery) disease"-tx-4-"coronary artery disease"-noun-0]|TX|1761/23|C14.280.647.250;C14.907.585.250
00000000|MMI|14.64|Diabetes Mellitus|C0011849|[dsyn]|["DIABETES MELLITUS"-tx-4-"diabetes mellitus"-noun-0]|TX|1664/17|C18.452.394.750;C19.246
00000000|MMI|14.64|Epilepsy|C0014544|[dsyn]|["SEIZURE DISORDER"-tx-4-"seizure disorder"-noun-0]|TX|1876/16|C10.228.140.490
00000000|MMI|14.64|Paraguay|C0030428|[geoa]|["PA"-tx-28-"PA"-noun-0]|TX|3612/2|Z01.107.757.656
00000000|MMI|14.64|Physicians|C0031831|[prog]|["DR"-tx-3-"Dr"-noun-0]|TX|1427/2|M01.526.485.810;N02.360.810
00000000|MMI|14.64|clopidogrel|C0070166|[orch,phsu]|["CLOPIDOGREL"-tx-3-"CLOPIDOGREL"-noun-0]|TX|1118/11|x.x.x.x
00000000|MMI|14.64|gabapentin|C0060926|[orch,phsu]|["GABAPENTIN"-tx-3-"GABAPENTIN"-noun-0]|TX|1082/10|x.x.x.x
00000000|MMI|14.64|methsuximide|C0109002|[orch,phsu]|["METHSUXIMIDE"-tx-3-"METHSUXIMIDE"-noun-0]|TX|1262/12|x.x.x.x
00000000|MMI|14.49|Graft material|C0181074|[bodm]|["{Graft}"-tx-13-"graft"-noun-0,"{Graft}"-tx-5-"graft"-noun-0,"{Graft}"-tx-4-"graft"-noun-0]|TX|[2731/5],[2762/5];2123/5;1850/5|
00000000|MMI|14.49|Grafting procedure|C1961139|[topp]|["Graft, NOS"-tx-13-"graft"-noun-0,"Graft, NOS"-tx-5-"graft"-noun-0,"Graft, NOS"-tx-4-"graft"-noun-0]|TX|[2731/5],[2762/5];2123/5;1850/5|
00000000|MMI|13.92|Patients|C0030705|[podg]|["*^patient"-tx-16-"Patient"-noun-0,"*^patient"-tx-12-"patient"-noun-0]|TX|2851/7;2715/7|M01.643
00000000|MMI|13.58|Educational process of instructing|C0039401|[edac]|["Instruction"-tx-2-"Instruction"-noun-0]|TX|[794/11],[963/11]|I02.903
00000000|MMI|13.14|Chronic Obstructive Airway Disease|C0024117|[dsyn]|["-- COPD"-tx-10-"COPD"-noun-0]|TX|2356/4|C08.381.495.389
00000000|MMI|13.08|Infantile Neuroaxonal Dystrophy|C0270724|[dsyn]|["PLAN"-tx-28-"PLAN"-noun-0]|TX|3551/4|C10.228.140.744
00000000|MMI|13.07|Diet|C0012155|[food]|["Diet"-tx-3-"DIET"-noun-0]|TX|1291/4|G07.203.650.240
00000000|MMI|13.03|Rabbi|C0684010|[prog]|["R."-tx-4-"R"-noun-0]|TX|1961/1|M01.526.799.500
00000000|MMI|13.03|Stomach|C0038351|[bpoc]|["STOMACH"-tx-2-"stomach"-noun-0]|TX|1016/7|A03.556.875.875
00000000|MMI|13.00|Lifting|C0206244|[acty]|["Lifting"-tx-3-"lifting"-noun-0]|TX|1378/7|G01.374.676.530;G01.595.540.530
00000000|MMI|13.00|Dilatation and Curettage|C0012358|[topp]|["D & C"-tx-1-"D/C"-noun-0]|TX|333/3|E04.157.310;E04.950.300.299
00000000|MMI|12.91|Libya|C0023634|[geoa]|["LY"-tx-1-"Ly"-noun-0]|TX|214/2|Z01.058.266.513
00000000|MMI|12.90|Automobiles|C0004381|[mnob]|["Car"-tx-1-"CAR"-noun-0]|TX|251/3|J01.937.500.100
00000000|MMI|12.90|Psychological Transfer|C0040671|[menp]|["TRANSFER"-tx-10-"transfer"-noun-0]|TX|2412/8|F02.463.425.910
00000000|MMI|11.79|MYOTONIC DYSTROPHY 1|C3250443|[dsyn]|["DM"-tx-20-"DM"-noun-0,"DM"-tx-10-"DM"-noun-0,"DM"-tx-4-"dm"-noun-0]|TX|3067/2;2328/2;1659/2|
00000000|MMI|11.79|Order (action)|C1705178|[acty]|["Order"-tx-28-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|3667/6;337/5;168/6|
00000000|MMI|11.79|Order (arrangement)|C1705176|[qlco]|["Order"-tx-28-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|3667/6;337/5;168/6|
00000000|MMI|11.79|Order (document)|C1705175|[inpr]|["Order"-tx-28-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|3667/6;337/5;168/6|
00000000|MMI|11.79|Order (taxonomic)|C1705177|[clas]|["Order"-tx-28-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|3667/6;337/5;168/6|
00000000|MMI|11.79|Permutation|C1882348|[qlco]|["Order"-tx-28-"ORDERS"-verb-0,"Order"-tx-1-"ORDER"-noun-0,"Order"-tx-1-"ORDERS"-verb-0]|TX|3667/6;337/5;168/6|
00000000|MMI|11.79|Sequence of Planned Assessment Schedule|C3889825|[inpr]|["ORDER"-tx-28-"ORDERS"-verb-0,"ORDER"-tx-1-"ORDER"-noun-0,"ORDER"-tx-1-"ORDERS"-verb-0]|TX|3667/6;337/5;168/6|
00000000|MMI|11.49|Allergy Specialty|C0002111|[bmod]|["Allergy"-tx-4-"ALLERGY"-noun-0]|TX|1459/7|H02.403.044
00000000|MMI|11.49|Complication Aspects|C1171258|[patf]|["complications"-tx-4-"Complications"-noun-0]|TX|1618/13|x.x.x
00000000|MMI|11.49|Methods aspects|C0025664|[inpr]|["procedures"-tx-4-"PROCEDURES"-noun-0]|TX|1910/10|x.x.x
00000000|MMI|11.49|Neurology speciality|C0027855|[bmod]|["NEURO"-tx-24-"Neuro"-adj-0]|TX|3212/5|H02.403.600
00000000|MMI|11.15|Negation|C1518422|[ftcn]|["Not"-tx-25-"not"-adv-0,"Not"-tx-24-"not"-adv-0,"Not"-tx-4-"NOT"-adv-0]|TX|3371/3;3311/3;1952/3|
00000000|MMI|11.10|Neurontin|C0678176|[orch,phsu]|["Neurontin"-tx-24-"neurontin"-noun-0,"Neurontin"-tx-10-"neurontin"-noun-0,"Neurontin"-tx-3-"NEURONTIN"-noun-0]|TX|3224/9;2568/9;1070/9|
00000000|MMI|10.76|Transfer Technique|C1705822|[ftcn]|["Transfer"-tx-10-"transfer"-noun-0,"Transferred"-tx-9-"Transferred"-verb-0,"Transferred"-tx-4-"transferred"-verb-0]|TX|2412/8;2280/11;2019/11|
00000000|MMI|10.73|S prime|C2603362|[clna]|["S'"-tx-4-"s"-prep-0,"S'"-tx-3-"("-noun-0]|TX|[1820/1],[1966/1];1420/1|
00000000|MMI|10.73|per second|C0565930|[qnco]|["/s"-tx-4-"s"-prep-0,"/s"-tx-3-"("-noun-0]|TX|[1820/1],[1966/1];1420/1|
00000000|MMI|10.42|% live|C1634625|[qlco]|["% live"-tx-22-"lives"-verb-0,"% live"-tx-11-"lives"-verb-0]|TX|3166/5;2662/5|
00000000|MMI|10.42|Diagnosis|C0011900|[fndg]|["DIAGNOSIS"-tx-4-"DIAGNOSIS"-noun-0]|TX|[1478/9],[1582/9]|E01
00000000|MMI|10.42|Diagnosis Study|C1704656|[resa]|["DIAGNOSIS"-tx-4-"DIAGNOSIS"-noun-0]|TX|[1478/9],[1582/9]|
00000000|MMI|10.42|Hold (action)|C1948035|[acty]|["Hold"-tx-20-"hold"-verb-0,"Hold"-tx-2-"hold"-verb-0]|TX|3088/4;840/4|
00000000|MMI|10.42|Hold - dosing instruction fragment|C1553387|[idcn]|["Hold"-tx-20-"hold"-verb-0,"Hold"-tx-2-"hold"-verb-0]|TX|3088/4;840/4|
00000000|MMI|10.42|Household composition|C0595998|[fndg]|["lives"-tx-22-"lives"-verb-0,"lives"-tx-11-"lives"-verb-0]|TX|3166/5;2662/5|
00000000|MMI|10.42|Live - Specimen Condition|C1548795|[qlco]|["Live"-tx-22-"lives"-verb-0,"Live"-tx-11-"lives"-verb-0]|TX|3166/5;2662/5|
00000000|MMI|10.42|Living Alone|C0439044|[fndg]|["Alone"-tx-22-"alone"-adj-0,"Alone"-tx-11-"alone"-adj-0]|TX|3172/5;2668/5|
00000000|MMI|10.42|Obesity Adverse Event|C1963185|[fndg]|["Obesity"-tx-4-"obesity"-noun-0]|TX|[1684/7],[1694/7]|
00000000|MMI|10.42|Reside|C2982691|[acty]|["Live"-tx-22-"lives"-verb-0,"Live"-tx-11-"lives"-verb-0]|TX|3166/5;2662/5|
00000000|MMI|10.42|Singular|C0205171|[qnco]|["Alone"-tx-22-"alone"-adj-0,"Alone"-tx-11-"alone"-adj-0]|TX|3172/5;2668/5|
00000000|MMI|10.42|To|C1883351|[qlco]|["To"-tx-20-"to"-adv-0,"To"-tx-16-"to"-adv-0]|TX|3085/2;2869/2|
00000000|MMI|10.42|alone - group size|C0679994|[grpa]|["alone"-tx-22-"alone"-adj-0,"alone"-tx-11-"alone"-adj-0]|TX|3172/5;2668/5|
00000000|MMI|10.42|hold - Data Operation|C3853841|[ftcn]|["hold"-tx-20-"hold"-verb-0,"hold"-tx-2-"hold"-verb-0]|TX|3088/4;840/4|
00000000|MMI|10.42|orders - HL7PublishingDomain|C3244315|[inpr]|["orders"-tx-28-"ORDERS"-verb-0,"orders"-tx-1-"ORDERS"-verb-0]|TX|3667/6;168/6|
00000000|MMI|9.91|Diet therapy|C0012159|[hlca]|["Diet"-tx-3-"DIET"-noun-0]|TX|1291/4|E02.642.249
00000000|MMI|9.86|Stenosis|C1261287|[patf]|["Stenosis"-tx-13-"stenosis"-noun-0]|TX|2768/8|C23.300.287
00000000|MMI|9.74|Ischemia|C0022116|[patf]|["Ischaemia, NOS"-tx-8-"ischemia"-noun-0]|TX|2269/8|C23.550.513
00000000|MMI|8.34|Allergic Reaction|C1527304|[patf]|["Allergy"-tx-4-"ALLERGY"-noun-0]|TX|1459/7|C20.543
00000000|MMI|8.34|Infection|C3714514|[patf]|["Infections"-tx-4-"Infections"-noun-0]|TX|1605/10|C01.539
00000000|MMI|7.70|3+ Answer to Question|C3838680|[fndg]|["3+"-tx-21-"3"-integer-0,"3+"-tx-2-"3"-fraction-0]|TX|3139/1;719/1|
00000000|MMI|7.70|3+ Score|C2827736|[qnco]|["3+"-tx-21-"3"-integer-0,"3+"-tx-2-"3"-fraction-0]|TX|3139/1;719/1|
00000000|MMI|7.70|3+ Score, WHO|C2981702|[clas]|["3+"-tx-21-"3"-integer-0,"3+"-tx-2-"3"-fraction-0]|TX|3139/1;719/1|
00000000|MMI|7.70|<3 (qualifier value)|C0439086|[qnco]|["<3"-tx-21-"3"-integer-0,"<3"-tx-2-"3"-fraction-0]|TX|3139/1;719/1|
00000000|MMI|7.70|Hospital admission|C0184666|[hlca]|["Admission"-tx-4-"Admission"-noun-0,"Admit"-tx-4-"ADMIT"-verb-0]|TX|1560/9;1472/5|
00000000|MMI|7.61|Arylsulfatase A, human|C3853627|[aapp,enzy]|["ASA"-tx-16-"ASA"-noun-0,"ASA"-tx-10-"ASA"-noun-0]|TX|2875/3;2502/3|
00000000|MMI|7.61|Condition|C0348080|[qlco]|["Condition"-tx-28-"CONDITION"-noun-0,"Condition"-tx-4-"Conditions"-noun-0]|TX|3527/9;1592/10|
00000000|MMI|7.61|Condition:Find:Pt:^Patient:Nom|C3864998|[clna]|["Condition"-tx-28-"CONDITION"-noun-0,"Condition"-tx-4-"Conditions"-noun-0]|TX|3527/9;1592/10|
00000000|MMI|7.61|Logical Condition|C1705253|[cnce]|["Condition"-tx-28-"CONDITION"-noun-0,"Condition"-tx-4-"Conditions"-noun-0]|TX|3527/9;1592/10|
00000000|MMI|7.57|Abortion consent:Finding:Point in time:^Patient:Document|C2360836|[clna]|["Patient"-tx-16-"Patient"-noun-0,"Patient"-tx-12-"patient"-noun-0]|TX|2851/7;2715/7|
00000000|MMI|7.57|Hysterectomy consent:Finding:Point in time:^Patient:Document|C2360838|[clna]|["Patient"-tx-16-"Patient"-noun-0,"Patient"-tx-12-"patient"-noun-0]|TX|2851/7;2715/7|
00000000|MMI|7.57|Sterilization consent:Finding:Point in time:^Patient:Document|C2360840|[clna]|["Patient"-tx-16-"Patient"-noun-0,"Patient"-tx-12-"patient"-noun-0]|TX|2851/7;2715/7|
00000000|MMI|7.55|Instructions:Text:Point in time:^Patient:Narrative|C3263700|[clna]|["Instructions"-tx-3-"Instructions"-noun-0,"Instructions"-tx-2-"Instructions"-noun-0]|TX|1212/12;726/12|
00000000|MMI|7.31|23|C0450348|[qnco]|["23"-tx-2-"23"-fraction-0,"23"-tx-1-"23"-fraction-0]|TX|721/2;43/2|
00000000|MMI|7.30|Patient Condition Code - Stable|C1547311|[inpr]|["Stable"-tx-28-"Stable"-adj-0,"Stable"-tx-26-"stable"-adj-0]|TX|3538/6;3389/6|
00000000|MMI|7.30|Stable status|C0205360|[qlco]|["STABLE"-tx-28-"Stable"-adj-0,"STABLE"-tx-26-"stable"-adj-0]|TX|3538/6;3389/6|
00000000|MMI|7.29|0%|C3842591|[fndg]|["0%"-tx-18-"0"-real_number-0,"0%"-tx-10-"0"-real_number-0]|TX|3057/1;2607/1|
00000000|MMI|7.29|4+ Answer to question|C3838679|[fndg]|["4+"-tx-23-"4"-integer-0,"4+"-tx-1-"4"-fraction-0]|TX|3209/1;95/1|
00000000|MMI|7.27|Alternate days|C0558287|[tmco]|["QOD"-tx-17-"QOD"-adv-0,"QOD"-tx-10-"QOD"-adv-0]|TX|2977/3;2543/3|
00000000|MMI|7.26|Summary (document)|C1706244|[inpr]|["Summary"-tx-28-"summary"-noun-0,"Summary"-tx-1-"SUMMARY"-noun-0]|TX|3569/7;362/7|
00000000|MMI|7.26|summary - ActRelationshipSubset|C1552616|[inpr]|["summary"-tx-28-"summary"-noun-0,"summary"-tx-1-"SUMMARY"-noun-0]|TX|3569/7;362/7|
00000000|MMI|7.22|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-9-"PUO"-noun-0,"puo"-tx-1-"PUO"-noun-0]|TX|2295/3;12/3|
00000000|MMI|7.22|6-Item Orientation-Memory-Concentration Test|C3831765|[inpr]|["OMC"-tx-6-"OMC"-noun-0,"OMC"-tx-4-"OMC"-noun-0]|TX|2159/3;2036/3|
00000000|MMI|7.22|Surgical transfer - action|C0348011|[ftcn]|["transferred"-tx-9-"Transferred"-verb-0,"transferred"-tx-4-"transferred"-verb-0]|TX|2280/11;2019/11|
00000000|MMI|7.20|Plavix|C0633084|[orch,phsu]|["Plavix"-tx-16-"plavix"-noun-0,"Plavix"-tx-3-"PLAVIX"-noun-0]|TX|2904/6;1109/6|
00000000|MMI|7.20|Call (Instruction)|C1947967|[ftcn]|["Call"-tx-27-"Call"-noun-0,"Call"-tx-4-"call"-noun-0]|TX|3479/4;1436/4|
00000000|MMI|7.20|Decision|C0679006|[menp]|["Call"-tx-27-"Call"-noun-0,"Call"-tx-4-"call"-noun-0]|TX|3479/4;1436/4|
00000000|MMI|7.20|Precursor B-cell lymphoblastic leukemia|C1292769|[neop]|["c all"-tx-27-"Call"-noun-0,"c all"-tx-4-"call"-noun-0]|TX|3479/4;1436/4|
00000000|MMI|7.14|Hospital course|C0489547|[fndg]|["Hospital course"-tx-11-"Hospital Course"-noun-0,"Hospital course"-tx-4-"HOSPITAL COURSE"-noun-1]|TX|2678/15;1991/15|
00000000|MMI|7.14|Hospital course:Finding:Point in time:^Patient:Narrative|C0488549|[clna]|["Hospital course"-tx-11-"Hospital Course"-noun-0,"Hospital course"-tx-4-"HOSPITAL COURSE"-noun-0]|TX|2678/15;1991/15|
00000000|MMI|7.09|50%|C3842586|[fndg]|["50%"-tx-28-"50"-integer-1,"50%"-tx-13-"50"-percentage-0]|TX|3637/2;2755/2|
00000000|MMI|7.09|<50|C3843766|[fndg]|["<50"-tx-28-"50"-integer-1,"<50"-tx-13-"50"-percentage-0]|TX|3637/2;2755/2|
00000000|MMI|7.09|Every morning|C0585329|[tmco]|["QAM"-tx-2-"QAM"-noun-0]|TX|[653/3],[687/3]|
00000000|MMI|7.04|House (environment)|C2003847|[mnob]|["House"-tx-18-"house"-adj-0,"House"-tx-3-"House"-noun-0]|TX|3011/5;1297/5|
00000000|MMI|7.04|Discontinued|C1444662|[fndg]|["D/C"-tx-1-"D/C"-noun-1,"DIS"-tx-1-"DIS"-noun-0]|TX|333/3;73/3|
00000000|MMI|7.03|Curriculum Vitae|C1880201|[inpr]|["Resume"-tx-4-"RESUME"-noun-0,"Resume"-tx-3-"resume"-noun-0]|TX|1981/6;1226/6|
00000000|MMI|7.03|Resume - Remote control command|C1550028|[idcn]|["Resume"-tx-4-"RESUME"-noun-0,"Resume"-tx-3-"resume"-noun-0]|TX|1981/6;1226/6|
00000000|MMI|7.03|resume - DataOperation|C3242342|[ftcn]|["resume"-tx-4-"RESUME"-noun-0,"resume"-tx-3-"resume"-noun-0]|TX|1981/6;1226/6|
00000000|MMI|7.02|Code|C0805701|[inpr]|["CODE"-tx-2-"CODE"-noun-0,"CODE"-tx-2-"code"-noun-0]|TX|419/4;437/4|
00000000|MMI|7.02|eTMF Content Model Code|C3889831|[inpr]|["Code"-tx-2-"CODE"-noun-0,"Code"-tx-2-"code"-noun-0]|TX|419/4;437/4|
00000000|MMI|7.02|Saphenous vein graft|C0729538|[bpoc]|["SVG"-tx-14-"SVG"-noun-0,"SVG"-tx-13-"SVG"-noun-0]|TX|2779/3;2725/3|
00000000|MMI|7.02|Scalable Vector Graphics|C2827658|[lang]|["SVG"-tx-14-"SVG"-noun-0,"SVG"-tx-13-"SVG"-noun-0]|TX|2779/3;2725/3|
00000000|MMI|7.01|mg/mg|C1319635|[qnco]|["mg/mg"-tx-3-"MG MG"-noun-0,"mg/mg"-tx-2-"MG MG"-noun-0]|TX|1135/2,1161/2;662/2,684/2|
00000000|MMI|6.97|Lima|C1047251|[euka]|["Lima"-tx-12-"LIMA"-adj-0,"Lima"-tx-5-"LIMA"-noun-0]|TX|2706/4;2093/4|
00000000|MMI|6.96|Beginning|C0439659|[tmco]|["Start"-tx-20-"start"-noun-0,"Start"-tx-2-"Starting"-adj-0]|TX|3127/5;702/8|
00000000|MMI|6.90|Posterior interventricular branch of right coronary artery|C0226047|[bpoc]|["PDA"-tx-13-"PDA"-noun-0,"PDA"-tx-5-"PDA"-noun-0]|TX|2740/3;2132/3|
00000000|MMI|5.18|ActInformationPrivacyReason <operations>|C3244305|[ftcn]|["operations"-tx-4-"OPERATIONS"-noun-0]|TX|1895/10|
00000000|MMI|5.18|Affecting|C0392760|[ftcn]|["Affecting"-tx-4-"affecting"-verb-0]|TX|1634/9|
00000000|MMI|5.18|Allergic disposition|C3539909|[dsyn]|["Allergy"-tx-4-"ALLERGY"-noun-0]|TX|1459/7|
00000000|MMI|5.18|Allergy - Physicians|C1554743|[prog]|["Allergy"-tx-4-"ALLERGY"-noun-0]|TX|1459/7|
00000000|MMI|5.18|Antimicrobial Resistance Result|C2827757|[lbtr]|["RESISTANT"-tx-16-"resistant"-adj-0]|TX|2879/9|
00000000|MMI|5.18|Approximate|C0332232|[qlco]|["Approximate"-tx-3-"approximate"-adj-0]|TX|1053/11|
00000000|MMI|5.18|Cardiovascular System Findings Domain|C3538987|[idcn]|["CV"-tx-12-"CV"-noun-0]|TX|2697/2|
00000000|MMI|5.18|Complication|C0009566|[patf]|["Complications"-tx-4-"Complications"-noun-0]|TX|1618/13|
00000000|MMI|5.18|Concern|C2699424|[idcn]|["Concerns"-tx-27-"concerns"-noun-0]|TX|3506/8|
00000000|MMI|5.18|Continuous|C0549178|[idcn]|["Continue"-tx-20-"continue"-verb-0]|TX|3076/8|
00000000|MMI|5.18|Delayed Release Dosage Form|C1707664|[bodm]|["DR"-tx-3-"Dr"-noun-0]|TX|1427/2|
00000000|MMI|5.18|Device to Subject Relationship Domain|C3540849|[inpr]|["DR"-tx-3-"Dr"-noun-0]|TX|1427/2|
00000000|MMI|5.18|Discharge date|C2361123|[tmco]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|119/14|
00000000|MMI|5.18|Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2361122|[clna]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|119/14|
00000000|MMI|5.18|Doctor - Title|C2348314|[cnce]|["Dr."-tx-3-"Dr"-noun-0]|TX|1427/2|
00000000|MMI|5.18|Doctor of Medicine|C1512018|[inpr]|["M.D."-tx-1-"M.D"-noun-0]|TX|414/3|
00000000|MMI|5.18|Extended Release Dosage Form|C1707968|[bodm]|["Extended Release"-tx-2-"EXTENDED RELEASE"-adj-0]|TX|906/16|
00000000|MMI|5.18|HL7PublishingSubSection <operations>|C3244306|[inpr]|["operations"-tx-4-"OPERATIONS"-noun-0]|TX|1895/10|
00000000|MMI|5.18|Hypertension Adverse Event|C1963138|[fndg]|["Hypertension"-tx-4-"hypertension"-noun-0]|TX|1740/12|
00000000|MMI|5.18|Interventional procedure|C0184661|[topp]|["PROCEDURES"-tx-4-"PROCEDURES"-noun-0]|TX|1910/10|
00000000|MMI|5.18|Involvement with|C1314939|[ftcn]|["Affecting"-tx-4-"affecting"-verb-0]|TX|1634/9|
00000000|MMI|5.18|Medications:-:Point in time:^Patient:-|C2598133|[clna]|["Medications"-tx-26-"medications"-noun-0]|TX|3451/11|
00000000|MMI|5.18|Medications:Presence or Identity:Duration of the study:^Patient:Nominal|C0802604|[clna]|["Medications"-tx-26-"medications"-noun-0]|TX|3451/11|
00000000|MMI|5.18|Not Applicable|C1272460|[qlco]|["NOT APPLICABLE"-tx-1-"Not Applicable"-adj-0]|TX|313/14|
00000000|MMI|5.18|Obstruction|C0028778|[patf]|["occluded"-tx-14-"occluded"-verb-0]|TX|2803/8|
00000000|MMI|5.18|Occluded|C1947917|[ftcn]|["Occluded"-tx-14-"occluded"-verb-0]|TX|2803/8|
00000000|MMI|5.18|Overnight|C0439583|[tmco]|["Overnight"-tx-22-"overnight"-adv-0]|TX|3150/9|
00000000|MMI|5.18|Package Type Not Applicable|C4049872|[ftcn]|["Not Applicable"-tx-1-"Not Applicable"-adj-0]|TX|313/14|
00000000|MMI|5.18|Pairing Events Domain|C3541314|[inpr]|["PA"-tx-28-"PA"-noun-0]|TX|3612/2|
00000000|MMI|5.18|Pharmaceutical Preparations|C0013227|[phsu]|["Medications"-tx-26-"medications"-noun-0]|TX|3451/11|D26
00000000|MMI|5.18|Present|C0150312|[qnco]|["Found"-tx-16-"found"-verb-0]|TX|2863/5|
00000000|MMI|5.18|Procedure (set of actions)|C2700391|[acty]|["Procedures"-tx-4-"PROCEDURES"-noun-0]|TX|1910/10|
00000000|MMI|5.18|Question (inquiry)|C1522634|[inpr]|["Question"-tx-27-"questions"-verb-0]|TX|3493/9|
00000000|MMI|5.18|Requirement|C1514873|[ftcn]|["Required"-tx-3-"Required"-verb-0]|TX|1042/8|
00000000|MMI|5.18|Resistance Process|C1514892|[phsf]|["Resistant"-tx-16-"resistant"-adj-0]|TX|2879/9|
00000000|MMI|5.18|Resistant (qualifier value)|C0332325|[ftcn]|["Resistant"-tx-16-"resistant"-adj-0]|TX|2879/9|
00000000|MMI|5.18|Response to antigens|C1314973|[phsf]|["ALLERGY"-tx-4-"ALLERGY"-noun-0]|TX|1459/7|
00000000|MMI|5.18|Restart|C1514902|[qlco]|["Restart"-tx-20-"restart"-verb-0]|TX|3105/7|
00000000|MMI|5.18|Saint Helena Islands|C0038108|[geoa]|["SH"-tx-11-"SH"-noun-0]|TX|2658/2|
00000000|MMI|5.18|Seizure Adverse Event|C1959629|[fndg]|["Seizure"-tx-4-"seizure"-noun-0]|TX|1866/7|
00000000|MMI|5.18|TAC1 wt Allele|C1705924|[gngm]|["NKA"-tx-4-"NKA"-noun-0]|TX|1468/3|
00000000|MMI|5.18|Tube feeding of patient|C0041281|[topp]|["tube feed"-tx-2-"tube feeds"-verb-0]|TX|812/10|
00000000|MMI|5.18|event cycle|C1511572|[tmco]|["Cycle"-tx-2-"cycle"-noun-0]|TX|832/5|
00000000|MMI|5.18|metoprolol succinate|C0724633|[orch,phsu]|["METOPROLOL SUCCINATE"-tx-2-"METOPROLOL SUCCINATE"-noun-0]|TX|885/20|
00000000|MMI|5.18|prescribed|C0278329|[hlca]|["Prescribed"-tx-26-"prescribed"-verb-0]|TX|3466/10|
00000000|MMI|5.18|resistant - Observation Interpretation Susceptibility|C1550464|[idcn]|["Resistant"-tx-16-"resistant"-adj-0]|TX|2879/9|
00000000|MMI|5.18|treatments and procedures|C0237403|[topp]|["treatments procedures"-tx-4-"TREATMENTS/PROCEDURES"-noun-0]|TX|1928/21|
00000000|MMI|3.75|Medication.discharge|C0806915|[fndg]|["Discharge medications"-tx-2-"DISCHARGE MEDICATIONS"-noun-0]|TX|460/21|
00000000|MMI|3.74|Domestic activities|C0441660|[dora]|["house activity"-tx-3-"House ACTIVITY"-noun-0]|TX|1334/5,1359/8|
00000000|MMI|3.70|Principal Diagnosis:-:Point in time:^Patient:-|C2598194|[clna]|["Principal Diagnosis"-tx-4-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|1493/9,1513/9|
00000000|MMI|3.70|Principal diagnosis|C0332137|[qlco]|["Principal Diagnosis"-tx-4-"PRINCIPAL DIAGNOSIS"-noun-0]|TX|1493/9,1513/9|
00000000|MMI|3.68|Admission activity|C0809949|[hlca]|["Admission"-tx-4-"Admission"-noun-0]|TX|1560/9|
00000000|MMI|3.68|Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2598112|[clna]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|79/14|
00000000|MMI|3.68|Arikaree language|C1555622|[lang]|["Ris"-tx-20-"RISS"-noun-0]|TX|3133/4|
00000000|MMI|3.68|Attending (action)|C1999232|[ftcn]|["attending"-tx-1-"Attending"-noun-0]|TX|375/9|
00000000|MMI|3.68|Attending (provider role)|C1547429|[prog]|["Attending"-tx-1-"Attending"-noun-0]|TX|375/9|
00000000|MMI|3.68|C-Circle|C3538933|[celc]|["CC"-tx-4-"CC"-noun-0]|TX|2011/2|
00000000|MMI|3.68|Chronic obstructive pulmonary disease of horses|C3714496|[dsyn]|["COPD"-tx-10-"COPD"-noun-0]|TX|2356/4|
00000000|MMI|3.68|Date of admission|C1302393|[tmco]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|79/14|
00000000|MMI|3.68|Methylcytosine Dioxygenase TET1|C2987138|[aapp,enzy]|["LCX"-tx-15-"LCx"-noun-0]|TX|2840/3|
00000000|MMI|3.68|RASL12 gene|C1428956|[gngm]|["RIS"-tx-20-"RISS"-noun-0]|TX|3133/4|
00000000|MMI|3.68|Scar Tissue|C0241158|[fndg]|["scar"-tx-8-"scar"-noun-0]|TX|2237/4|
00000000|MMI|3.68|Status|C0449438|[qlco]|["Status"-tx-2-"STATUS"-noun-0]|TX|424/6|
00000000|MMI|3.68|Stress|C0038435|[fndg]|["Stress"-tx-8-"stress"-noun-0]|TX|2213/6|
00000000|MMI|3.68|TET1 gene|C1428863|[gngm]|["LCX"-tx-15-"LCx"-noun-0]|TX|2840/3|
00000000|MMI|3.68|TET1 wt Allele|C2987137|[gngm]|["LCX"-tx-15-"LCx"-noun-0]|TX|2840/3|
00000000|MMI|3.68|discharge diagnosis|C1555319|[fndg]|["Discharge diagnosis"-tx-4-"DISCHARGE DIAGNOSIS"-noun-0]|TX|1503/19|
00000000|MMI|3.65|Dose number|C1115464|[qnco]|["Dose number"-tx-3-"Number Doses"-noun-0]|TX|1026/6,1036/5|
00000000|MMI|3.65|Dose number:Number:Point in time:^Patient:Quantitative|C1114758|[clna]|["Dose number"-tx-3-"Number Doses"-noun-0]|TX|1026/6,1036/5|
00000000|MMI|3.65|Report status|C0586177|[fndg]|["Report status"-tx-1-"Report Status"-noun-0]|TX|104/13|
00000000|MMI|3.64|Conditional|C1701901|[qlco]|["Contingent"-tx-1-"CONTINGENT"-noun-0]|TX|297/10|
00000000|MMI|3.64|Entered|C1521975|[qlco]|["Entered"-tx-28-"ENTERED"-verb-0]|TX|3577/7|
00000000|MMI|3.63|/40|C0439509|[tmco]|["/40"-tx-10-"40"-integer-0]|TX|2557/2|
00000000|MMI|3.63|40%|C3842587|[qnco]|["40%"-tx-10-"40"-integer-0]|TX|2557/2|
00000000|MMI|3.63|ActInformationPrivacyReason <service>|C3245478|[idcn]|["service"-tx-1-"Service"-noun-0]|TX|242/7|
00000000|MMI|3.63|Disposition|C0743223|[idcn]|["Disposition"-tx-2-"DISPOSITION"-noun-0]|TX|442/11|
00000000|MMI|3.63|Disposition Domain|C1705555|[inpr]|["Disposition"-tx-2-"DISPOSITION"-noun-0]|TX|442/11|
00000000|MMI|3.63|Services|C0557854|[ocac]|["Service"-tx-1-"Service"-noun-0]|TX|242/7|
00000000|MMI|3.63|Software Service|C2825316|[mnob]|["Service"-tx-1-"Service"-noun-0]|TX|242/7|
00000000|MMI|3.61|Pharmacogenomics Trial Characteristics Domain|C3714755|[inpr]|["PT"-tx-26-"pt"-noun-0]|TX|3386/2|
00000000|MMI|3.61|Physical therapy (field)|C0699718|[bmod]|["PT"-tx-26-"pt"-noun-0]|TX|3386/2|
00000000|MMI|3.61|Planned|C1301732|[ftcn]|["Plan"-tx-28-"PLAN"-noun-0]|TX|3551/4|
00000000|MMI|3.61|Treatment Plan|C0599880|[inpr]|["Plan"-tx-28-"PLAN"-noun-0]|TX|3551/4|
00000000|MMI|3.60|BBS9 wt Allele|C3889128|[gngm]|["D1"-tx-5-"D1"-noun-0]|TX|2098/2|
00000000|MMI|3.60|Basal Diet|C2983588|[food]|["DIET"-tx-3-"DIET"-noun-0]|TX|1291/4|
00000000|MMI|3.60|Diet (animal life circumstance)|C3668949|[food]|["Diet"-tx-3-"DIET"-noun-0]|TX|1291/4|
00000000|MMI|3.60|LMOD1 gene|C1416886|[gngm]|["D1"-tx-5-"D1"-noun-0]|TX|2098/2|
00000000|MMI|3.60|Special Diet Therapy|C1519433|[topp]|["DIET"-tx-3-"DIET"-noun-0]|TX|1291/4|
00000000|MMI|3.60|Celontin|C0729224|[orch,phsu]|["Celontin"-tx-3-"CELONTIN"-noun-0]|TX|1251/8|
00000000|MMI|3.59|Room|C1547703|[spco]|["Room"-tx-1-"Room"-noun-0]|TX|228/4|
00000000|MMI|3.59|End|C0444930|[spco]|["End"-tx-28-"END"-noun-0]|TX|3650/3|
00000000|MMI|3.59|Presentation|C0449450|[idcn]|["Presented"-tx-6-"Presented"-verb-0]|TX|2146/9|
00000000|MMI|3.59|Responsible to|C1273518|[fndg]|["Responsible"-tx-4-"Responsible"-adj-0]|TX|1524/11|
00000000|MMI|3.59|Stop (qualifier value)|C2746065|[tmco]|["End"-tx-28-"END"-noun-0]|TX|3650/3|
00000000|MMI|3.58|Today|C0310367|[antb,orch]|["Today"-tx-2-"Today"-noun-0]|TX|711/5|
00000000|MMI|3.58|Today (temporal qualifier)|C0750526|[tmco]|["Today"-tx-2-"Today"-noun-0]|TX|711/5|
00000000|MMI|3.57|Empty (qualifier)|C1880497|[qlco]|["Empty"-tx-2-"empty"-adj-0]|TX|1010/5|
00000000|MMI|3.57|Entire stomach|C1278920|[bpoc]|["Stomach"-tx-2-"stomach"-noun-0]|TX|1016/7|
00000000|MMI|3.57|Gastric Tissue|C1517454|[tisu]|["STOMACH"-tx-2-"stomach"-noun-0]|TX|1016/7|
00000000|MMI|3.57|R prime|C2603358|[clna]|["R'"-tx-4-"R"-noun-0]|TX|1961/1|
00000000|MMI|3.57|Right|C0205090|[spco]|["R-"-tx-4-"R"-noun-0]|TX|1961/1|
00000000|MMI|3.57|Stomach structure|C3714551|[bpoc]|["Stomach"-tx-2-"stomach"-noun-0]|TX|1016/7|
00000000|MMI|3.56|Area|C0205146|[spco]|["AREA"-tx-8-"area"-noun-0]|TX|2252/4|
00000000|MMI|3.56|Changed status|C0443172|[qnco]|["change"-tx-16-"change"-verb-0]|TX|2894/6|
00000000|MMI|3.56|Changing|C0392747|[ftcn]|["Change"-tx-16-"change"-verb-0]|TX|2894/6|
00000000|MMI|3.56|Delta (difference)|C1705241|[qnco]|["Change"-tx-16-"change"-verb-0]|TX|2894/6|
00000000|MMI|3.56|Geographic Locations|C0017446|[geoa]|["Area"-tx-8-"area"-noun-0]|TX|2252/4|Z01
00000000|MMI|3.56|Monday|C0585024|[tmco]|["Monday"-tx-6-"Monday"-noun-0]|TX|2166/6|
00000000|MMI|3.55|List|C0745732|[cnce]|["List"-tx-24-"listed"-verb-0]|TX|3277/6|
00000000|MMI|3.55|Sequence Data Type|C3272378|[inpr]|["LIST"-tx-24-"listed"-verb-0]|TX|3277/6|
00000000|MMI|3.55|Leucovorin Calcium|C0731033|[orch,phsu,vita]|["LV"-tx-13-"LV"-noun-0]|TX|2748/2|
00000000|MMI|3.55|Liposome Vesicle|C1881413|[chvs]|["LV"-tx-13-"LV"-noun-0]|TX|2748/2|
00000000|MMI|3.55|Stenosis (invertebrate)|C2632116|[euka]|["Stenosis"-tx-13-"stenosis"-noun-0]|TX|2768/8|
00000000|MMI|3.55|Stenosis Morphology|C0678234|[qlco]|["Stenosis"-tx-13-"stenosis"-noun-0]|TX|2768/8|
00000000|MMI|3.55|Used by|C1273517|[fndg]|["used"-tx-1-"USED"-verb-1]|TX|346/4|
00000000|MMI|3.53|Doctor of Chiropractic|C1512015|[inpr]|["D.C."-tx-1-"D/C"-noun-0]|TX|333/3|
00000000|MMI|3.52|Switch Device Component|C1707719|[mnob]|["Switch"-tx-18-"switched"-verb-0]|TX|2990/8|
00000000|MMI|3.51|Digoxin 0.25 MG|C0985544|[clnd]|["Digoxin 0.25 MG"-tx-2-"DIGOXIN 0.25 MG"-noun-0]|TX|483/15|
00000000|MMI|3.50|Causing|C0678227|[ftcn]|["Causing"-tx-4-"Causing"-adj-0]|TX|1552/7|
00000000|MMI|3.50|Diagnosis Type - Final|C1546485|[idcn]|["Final"-tx-1-"FINAL"-adj-0]|TX|152/5|
00000000|MMI|3.50|End-stage|C0205088|[qlco]|["Final"-tx-1-"FINAL"-adj-0]|TX|152/5|
00000000|MMI|3.50|Final|C3853528|[tmco]|["Final"-tx-1-"FINAL"-adj-0]|TX|152/5|
00000000|MMI|3.50|Identifier|C0600091|[inpr]|["ID"-tx-4-"ID"-noun-0]|TX|2008/2|
00000000|MMI|3.50|Immune diffusion|C1441613|[lbpr]|["ID"-tx-4-"ID"-noun-0]|TX|2008/2|
00000000|MMI|3.50|Inferior|C0542339|[spco]|["INFERIOR"-tx-8-"inferior"-adj-0]|TX|2228/8|
00000000|MMI|3.50|Yes (indicator)|C1705108|[cnce]|["YES"-tx-1-"YES"-noun-0]|TX|371/3|
00000000|MMI|3.50|Yes - Yes/no indicator|C1549445|[idcn]|["Yes"-tx-1-"YES"-noun-0]|TX|371/3|
00000000|MMI|3.50|dictated - DocumentCompletion|C1609990|[idcn]|["Dictated"-tx-28-"dictated"-adj-0]|TX|3560/8|
00000000|MMI|3.50|dictated - ParticipationMode|C1548384|[ftcn]|["dictated"-tx-28-"dictated"-adj-0]|TX|3560/8|
00000000|MMI|3.50|inferiority|C0678975|[socb]|["inferior"-tx-8-"inferior"-adj-0]|TX|2228/8|
00000000|MMI|3.50|nuclear|C0521447|[spco]|["Nuclear"-tx-8-"Nuclear"-adj-0]|TX|2205/7|
00000000|MMI|3.49|Readiness|C1318963|[fndg]|["Readiness"-tx-26-"ready"-adj-0]|TX|3400/5|
00000000|MMI|3.49|milligram/day|C0439422|[qnco]|["day mg"-tx-2-"DAY MG"-noun-0]|TX|550/3,567/2|
00000000|MMI|3.49|history of - * (non-specific)|C0455483|[fndg]|["h o"-tx-5-"h/o"-noun-0]|TX|2084/3|
00000000|MMI|3.48|Administration procedure|C1533734|[topp]|["Treatment"-tx-4-"Treatment"-noun-0]|TX|1644/9|
00000000|MMI|3.48|Biomaterial Treatment|C1705169|[cnce]|["Treatment"-tx-4-"Treatment"-noun-0]|TX|1644/9|
00000000|MMI|3.48|Full|C0443225|[qlco]|["Full"-tx-2-"Full"-adj-0]|TX|432/4|
00000000|MMI|3.48|Positive|C1446409|[qlco]|["Positive"-tx-4-"positive"-adj-0]|TX|2045/8|
00000000|MMI|3.48|Positive Charge|C2825490|[qlco]|["Positive"-tx-4-"positive"-adj-0]|TX|2045/8|
00000000|MMI|3.48|Positive Finding|C1514241|[fndg]|["POSITIVE"-tx-4-"positive"-adj-0]|TX|2045/8|
00000000|MMI|3.48|Positive Number|C3812269|[cnce]|["Positive"-tx-4-"positive"-adj-0]|TX|2045/8|
00000000|MMI|3.48|Therapeutic procedure|C0087111|[topp]|["Treatment"-tx-4-"Treatment"-noun-0]|TX|1644/9|E02
00000000|MMI|3.48|Treating|C1522326|[ftcn]|["Treatment"-tx-4-"Treatment"-noun-0]|TX|1644/9|
00000000|MMI|3.48|Treatment Epoch|C3538994|[resa]|["TREATMENT"-tx-4-"Treatment"-noun-0]|TX|1644/9|
00000000|MMI|3.48|percent positive cells|C0439178|[qnco]|["% Positive"-tx-4-"positive"-adj-0]|TX|2045/8|
00000000|MMI|3.48|treatment - ActInformationManagementReason|C3887704|[hlca]|["treatment"-tx-4-"Treatment"-noun-0]|TX|1644/9|
00000000|MMI|3.47|30 Minutes|C1442458|[tmco]|["1/2 hr"-tx-2-"1 hr 2"-noun-0]|TX|845/4,860/1|
00000000|MMI|3.47|Diagnostic interview schedule|C0451119|[inpr]|["DIS"-tx-1-"DIS"-noun-0]|TX|73/3|
00000000|MMI|3.47|Medical History|C0262926|[fndg]|["PMH"-tx-10-"PMH"-noun-0]|TX|2310/3|
00000000|MMI|3.47|Primary|C0205225|[qlco]|["Principal"-tx-4-"PRINCIPAL"-adj-0]|TX|1493/9|
00000000|MMI|3.47|Subject Continuance|C2826258|[evnt]|["CONT"-tx-24-"Cont"-noun-0]|TX|3219/4|
00000000|MMI|3.47|Teaching principal|C0401925|[prog]|["Principal"-tx-4-"PRINCIPAL"-adj-0]|TX|1493/9|
00000000|MMI|3.46|Exercise-induced angina|C0577698|[sosy]|["Exertional angina"-tx-6-"exertional angina"-noun-0]|TX|2178/17|
00000000|MMI|3.46|Afternoon|C0439550|[tmco]|["Afternoon"-tx-2-"afternoon"-noun-0]|TX|762/9|
00000000|MMI|3.46|Anti-Drug Antibody|C3811629|[aapp,imft]|["ADA"-tx-3-"ADA"-noun-0]|TX|1342/3|
00000000|MMI|3.46|CA8 gene|C1413051|[gngm]|["CALS"-tx-3-"cals"-noun-0]|TX|1351/4|
00000000|MMI|3.46|Genus Ada|C1060325|[plnt]|["Ada"-tx-3-"ADA"-noun-0]|TX|1342/3|
00000000|MMI|3.46|Nutrition, Calories|C1556156|[qnco]|["cals"-tx-3-"cals"-noun-0]|TX|1351/4|
00000000|MMI|3.46|Study Day|C2826182|[tmco]|["DY"-tx-3-"dy"-noun-0]|TX|1356/2|
00000000|MMI|3.46|kilocalorie|C0439259|[qnco]|["Cal"-tx-3-"cals"-noun-0]|TX|1351/4|
00000000|MMI|3.45|Cholesterol measurement test|C0201950|[lbpr]|["CHOL"-tx-3-"chol"-noun-0]|TX|1309/4|
00000000|MMI|3.45|SAT1 protein, human|C2744672|[aapp,enzy]|["SAT"-tx-3-"sat"-noun-0]|TX|1318/3|
00000000|MMI|3.45|SAT1 wt Allele|C1705827|[gngm]|["SAT"-tx-3-"sat"-noun-0]|TX|1318/3|
00000000|MMI|3.45|Additional comments|C1830770|[fndg]|["Additional comments"-tx-26-"ADDITIONAL COMMENTS"-noun-0]|TX|3414/19|
00000000|MMI|3.45|Room of building - Study|C0557651|[mnob]|["Study"-tx-4-"Study"-noun-0]|TX|1542/5|
00000000|MMI|3.45|Study|C2603343|[resa]|["Study"-tx-4-"Study"-noun-0]|TX|1542/5|
00000000|MMI|3.45|Bedtime (qualifier value)|C0521112|[tmco]|["Bedtime"-tx-2-"BEDTIME"-noun-0]|TX|672/7|
00000000|MMI|3.45|Every evening|C0585330|[tmco]|["QPM"-tx-2-"QPM"-noun-0]|TX|665/3|
00000000|MMI|3.45|Once a day, in the evening|C1275568|[tmco]|["qPM"-tx-2-"QPM"-noun-0]|TX|665/3|
00000000|MMI|3.44|CXADR wt Allele|C3540475|[gngm]|["CAR"-tx-1-"CAR"-noun-0]|TX|251/3|
00000000|MMI|3.44|Coxsackievirus and Adenovirus Receptor|C3539542|[aapp]|["CAR"-tx-1-"CAR"-noun-0]|TX|251/3|
00000000|MMI|3.44|NR1I3 wt Allele|C3811749|[gngm]|["CAR"-tx-1-"CAR"-noun-0]|TX|251/3|
00000000|MMI|3.44|Part|C0449719|[spco]|["Part"-tx-4-"Part"-noun-0]|TX|1431/4|
00000000|MMI|3.44|Part Dosing Unit|C1709471|[qnco]|["Part"-tx-4-"Part"-noun-0]|TX|1431/4|
00000000|MMI|3.44|Behavior Rating Inventory of Executive Function, Preschool Version|C4055387|[inpr]|["BRIEF-P"-tx-4-"p BRIEF"-adj-0]|TX|1968/1,1975/5|
00000000|MMI|3.43|Anterior|C0205094|[ftcn]|["ANTERIOR"-tx-8-"anterior"-adj-0]|TX|2260/8|
00000000|MMI|3.43|Clinical Study Follow-up|C3274571|[hlca]|["FOLLOW-UP"-tx-3-"FOLLOW UP"-adj-0]|TX|1399/9|
00000000|MMI|3.43|Follow-Up Report|C1704685|[inpr]|["Follow-Up"-tx-3-"FOLLOW UP"-adj-0]|TX|1399/9|
00000000|MMI|3.43|Follow-up status|C0589120|[fndg]|["Follow-up"-tx-3-"FOLLOW UP"-adj-1]|TX|1399/9|
00000000|MMI|3.43|Organ